GSDMD and atherosclerosis: Genetic deletion of Gsdmd or pharmacological inhibition with necrosulfonamide reduces infarct size and heart failure in a mouse model of acute myocardial infarction [32], underlining the involvement of GSDMD in cardiovascular disease and the possibility for using it as a pharmacological target in atherosclerosis.